# Hewlett Packard Enterprise timeline

entity: /record/hewlett-packard-enterprise.md  
id: ent_hewlett-packard-enterprise  


## undated

- undated | fiscal_year_end | 10-31 | valid | [clm_12FF541C6114](/claim/clm_12FF541C6114.md)
- undated | cik | 0001645590 | valid | [clm_90DC7F8EBDE9](/claim/clm_90DC7F8EBDE9.md)
- undated | state_of_incorporation | DE | valid | [clm_AB4EE479295A](/claim/clm_AB4EE479295A.md)
- undated | ticker | HPE-PC | valid | [clm_AC3E842E3F76](/claim/clm_AC3E842E3F76.md)
- undated | sic_industry | Computer & office Equipment (3570) | valid | [clm_C0423CFB0BDD](/claim/clm_C0423CFB0BDD.md)
- undated | registrant_name | Hewlett Packard Enterprise Co | valid | [clm_C80A9202699B](/claim/clm_C80A9202699B.md)
- undated | ticker | HPE | valid | [clm_F083E09A160D](/claim/clm_F083E09A160D.md)
- undated | listed_on | NYSE | valid | [clm_FEB819A20231](/claim/clm_FEB819A20231.md)

## 2010

- 2010-10-25 | x_username | HPE | unverified | [clm_8FB3EA8D2BB9](/claim/clm_8FB3EA8D2BB9.md)

## 2012

- 2012-10-31 to 2013-10-31 | cash_and_equivalents | 2,134,000,000 United States dollar | superseded | [clm_322768F40CA9](/claim/clm_322768F40CA9.md)
- 2012-11-01 to 2013-10-31 | revenue | 57,371,000,000 United States dollar | superseded | [clm_10D8E36F9ACF](/claim/clm_10D8E36F9ACF.md)
- 2012-11-01 to 2013-10-31 | net_income | 2,051,000,000 United States dollar | superseded | [clm_5A26BB688780](/claim/clm_5A26BB688780.md)
- 2012-11-01 to 2013-10-31 | operating_income | 2,952,000,000 United States dollar | superseded | [clm_EE1895C6E223](/claim/clm_EE1895C6E223.md)

## 2013

- 2013-10-31 to 2013-11-01 | net_income | 2,051,000,000 United States dollar | superseded | [clm_4DB0184EA5A8](/claim/clm_4DB0184EA5A8.md)
- 2013-10-31 to 2013-11-01 | revenue | 57,371,000,000 United States dollar | superseded | [clm_6B15DFA94E0C](/claim/clm_6B15DFA94E0C.md)
- 2013-10-31 to 2014-10-31 | cash_and_equivalents | 2,182,000,000 United States dollar | superseded | [clm_7F30ABD5768F](/claim/clm_7F30ABD5768F.md)
- 2013-10-31 to 2014-10-31 | research_and_development | 1,956,000,000 United States dollar | superseded | [clm_813E52EC1FA5](/claim/clm_813E52EC1FA5.md)
- 2013-10-31 to 2013-11-01 | operating_income | 2,952,000,000 United States dollar | superseded | [clm_D802C9C896B8](/claim/clm_D802C9C896B8.md)
- 2013-11-01 to 2014-10-31 | revenue | 55,123,000,000 United States dollar | superseded | [clm_5FC221EA3B15](/claim/clm_5FC221EA3B15.md)
- 2013-11-01 to 2014-10-31 | operating_income | 2,335,000,000 United States dollar | superseded | [clm_74813F46F3E2](/claim/clm_74813F46F3E2.md)
- 2013-11-01 to 2014-10-31 | net_income | 1,648,000,000 United States dollar | superseded | [clm_900D36D9CD62](/claim/clm_900D36D9CD62.md)

## 2014

- 2014-10-31 to 2015-10-31 | total_assets | 65,071,000,000 United States dollar | superseded | [clm_462519A41414](/claim/clm_462519A41414.md)
- 2014-10-31 to 2014-11-01 | operating_income | 2,335,000,000 United States dollar | superseded | [clm_5F73EA63C82A](/claim/clm_5F73EA63C82A.md)
- 2014-10-31 to 2014-11-01 | revenue | 55,123,000,000 United States dollar | superseded | [clm_7AC6CF2BCE1D](/claim/clm_7AC6CF2BCE1D.md)
- 2014-10-31 to 2015-01-31 | cash_and_equivalents | 2,319,000,000 United States dollar | superseded | [clm_88D1B0F50E05](/claim/clm_88D1B0F50E05.md)
- 2014-10-31 to 2015-10-31 | total_equity | 36,776,000,000 United States dollar | superseded | [clm_896CE1BFC42E](/claim/clm_896CE1BFC42E.md)
- 2014-10-31 to 2014-11-01 | net_income | 1,648,000,000 United States dollar | superseded | [clm_ABF6E02C83D0](/claim/clm_ABF6E02C83D0.md)
- 2014-10-31 to 2015-10-31 | research_and_development | 2,197,000,000 United States dollar | superseded | [clm_DED1EC455E8B](/claim/clm_DED1EC455E8B.md)
- 2014-11-01 to 2015-10-31 | revenue | 52,107,000,000 United States dollar | superseded | [clm_17E3E97E9FC1](/claim/clm_17E3E97E9FC1.md)
- 2014-11-01 to 2015-10-31 | operating_income | 1,523,000,000 United States dollar | superseded | [clm_C5CB698D0723](/claim/clm_C5CB698D0723.md)
- 2014-11-01 to 2015-10-31 | net_income | 2,461,000,000 United States dollar | superseded | [clm_F682327630F8](/claim/clm_F682327630F8.md)

## 2015

- 2015-01-01 | board_member | Gary Reiner | unverified | [clm_07683D623932](/claim/clm_07683D623932.md)
- 2015-01-01 | board_member | Ray Ozzie | unverified | [clm_261B674A92E8](/claim/clm_261B674A92E8.md)
- 2015-01-01 | board_member | Patricia Russo | unverified | [clm_36003F8FA9D1](/claim/clm_36003F8FA9D1.md)
- 2015-01-01 | board_member | Raymond J. Lane | unverified | [clm_3AFB59937A90](/claim/clm_3AFB59937A90.md)
- 2015-01-01 | board_member | Ann Livermore | unverified | [clm_3EE5E23220BF](/claim/clm_3EE5E23220BF.md)
- 2015-01-01 | board_member | Lip-Bu Tan | unverified | [clm_9A2068A46A56](/claim/clm_9A2068A46A56.md)
- 2015-01-01 | board_member | Pamela Carter | unverified | [clm_F57E8BA48B30](/claim/clm_F57E8BA48B30.md)
- 2015-01-31 to 2015-04-30 | quarterly_operating_income | 732,000,000 United States dollar | superseded | [clm_43A60571344C](/claim/clm_43A60571344C.md)
- 2015-01-31 to 2015-04-30 | quarterly_research_and_development | 532,000,000 United States dollar | superseded | [clm_5750C14781FE](/claim/clm_5750C14781FE.md)
- 2015-01-31 to 2015-04-30 | quarterly_revenue | 13,053,000,000 United States dollar | superseded | [clm_5797D30EE172](/claim/clm_5797D30EE172.md)
- 2015-01-31 to 2015-04-30 | cash_and_equivalents | 2,512,000,000 United States dollar | superseded | [clm_70AD936EFD6F](/claim/clm_70AD936EFD6F.md)
- 2015-01-31 to 2015-04-30 | quarterly_net_income | 547,000,000 United States dollar | superseded | [clm_D5D684F8ECE2](/claim/clm_D5D684F8ECE2.md)
- 2015-04-30 to 2015-07-31 | cash_and_equivalents | 2,719,000,000 United States dollar | superseded | [clm_573285E7E987](/claim/clm_573285E7E987.md)
- 2015-04-30 to 2015-07-31 | quarterly_net_income | 305,000,000 United States dollar | superseded | [clm_5D226B4FADDE](/claim/clm_5D226B4FADDE.md)
- 2015-04-30 to 2015-07-31 | quarterly_operating_income | 428,000,000 United States dollar | superseded | [clm_8C6E973E3376](/claim/clm_8C6E973E3376.md)
- 2015-04-30 to 2015-07-31 | quarterly_research_and_development | 552,000,000 United States dollar | superseded | [clm_92181ECF6E29](/claim/clm_92181ECF6E29.md)
- 2015-04-30 to 2015-07-31 | quarterly_revenue | 12,549,000,000 United States dollar | superseded | [clm_E7427431427C](/claim/clm_E7427431427C.md)
- 2015-07-31 to 2016-01-31 | quarterly_research_and_development | 602,000,000 United States dollar | superseded | [clm_2765A227B833](/claim/clm_2765A227B833.md)
- 2015-07-31 to 2016-01-31 | quarterly_operating_income | 244,000,000 United States dollar | superseded | [clm_436943A2C054](/claim/clm_436943A2C054.md)
- 2015-07-31 to 2016-01-31 | quarterly_net_income | 224,000,000 United States dollar | superseded | [clm_61C191BC80DE](/claim/clm_61C191BC80DE.md)
- 2015-07-31 to 2015-10-31 | cash_and_equivalents | 2,774,000,000 United States dollar | superseded | [clm_A62934FE9B6A](/claim/clm_A62934FE9B6A.md)
- 2015-07-31 to 2016-01-31 | quarterly_revenue | 13,057,000,000 United States dollar | superseded | [clm_A9EF746157F0](/claim/clm_A9EF746157F0.md)
- 2015-10-31 to 2016-10-31 | research_and_development | 2,338,000,000 United States dollar | superseded | [clm_044C6E3E6B64](/claim/clm_044C6E3E6B64.md)
- 2015-10-31 to 2016-01-31 | total_assets | 81,270,000,000 United States dollar | superseded | [clm_120B88FF8B88](/claim/clm_120B88FF8B88.md)
- 2015-10-31 to 2016-01-31 | total_assets | 79,862,000,000 United States dollar | superseded | [clm_122892CB304A](/claim/clm_122892CB304A.md)
- 2015-10-31 to 2016-10-31 | revenue | 52,107,000,000 United States dollar | superseded | [clm_481DD32F2212](/claim/clm_481DD32F2212.md)
- 2015-10-31 to 2016-01-31 | cash_and_equivalents | 9,842,000,000 United States dollar | superseded | [clm_8773E2852AD8](/claim/clm_8773E2852AD8.md)
- 2015-10-31 to 2015-11-01 | net_income | 2,461,000,000 United States dollar | superseded | [clm_A0AB98C18B77](/claim/clm_A0AB98C18B77.md)
- 2015-10-31 to 2016-01-31 | total_equity | 33,535,000,000 United States dollar | superseded | [clm_BCF7CDCC8017](/claim/clm_BCF7CDCC8017.md)
- 2015-10-31 to 2015-11-01 | operating_income | 1,523,000,000 United States dollar | superseded | [clm_F43BDBEDBDAE](/claim/clm_F43BDBEDBDAE.md)
- 2015-11-01 to 2016-10-31 | net_income | 3,161,000,000 United States dollar | superseded | [clm_16DEF9011078](/claim/clm_16DEF9011078.md)

## undated

- undated | website | https://www.hpe.com/ | unverified | [clm_491437332D38](/claim/clm_491437332D38.md)
- undated | legal_form | public company | unverified | [clm_64455617D04B](/claim/clm_64455617D04B.md)
- undated | member_of | Wi-Fi Alliance | unverified | [clm_B4AD89257CC1](/claim/clm_B4AD89257CC1.md)
- undated | member_of | CVE Numbering Authority | unverified | [clm_BA1AA1FE86FC](/claim/clm_BA1AA1FE86FC.md)

## 2015

- 2015-11-01 to 2016-10-31 | operating_income | 4,150,000,000 United States dollar | superseded | [clm_C876F53C1056](/claim/clm_C876F53C1056.md)

## undated

- undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_E29278396432](/claim/clm_E29278396432.md)

## 2015

- 2015-11-30 to 2016-02-29 | shares_outstanding | 1,742,520,126 shares | superseded | [clm_E7D11D5D2FA8](/claim/clm_E7D11D5D2FA8.md)

## 2016

- 2016-01-31 to 2016-04-30 | total_equity | 31,249,000,000 United States dollar | superseded | [clm_36F81963EE03](/claim/clm_36F81963EE03.md)
- 2016-01-31 to 2016-04-30 | quarterly_net_income | 267,000,000 United States dollar | superseded | [clm_786A9474D186](/claim/clm_786A9474D186.md)
- 2016-01-31 to 2016-04-30 | total_assets | 77,352,000,000 United States dollar | superseded | [clm_8FED10D8910F](/claim/clm_8FED10D8910F.md)
- 2016-01-31 to 2016-04-30 | quarterly_revenue | 12,724,000,000 United States dollar | superseded | [clm_929FD68ED4FB](/claim/clm_929FD68ED4FB.md)
- 2016-01-31 to 2016-04-30 | cash_and_equivalents | 8,505,000,000 United States dollar | superseded | [clm_980E44F65978](/claim/clm_980E44F65978.md)
- 2016-01-31 to 2016-04-30 | quarterly_research_and_development | 585,000,000 United States dollar | superseded | [clm_D072C5B92243](/claim/clm_D072C5B92243.md)
- 2016-01-31 to 2016-04-30 | quarterly_operating_income | 384,000,000 United States dollar | superseded | [clm_ED98576EEF5A](/claim/clm_ED98576EEF5A.md)
- 2016-02-29 to 2016-05-31 | shares_outstanding | 1,716,564,087 shares | superseded | [clm_BA1E39BC5AEB](/claim/clm_BA1E39BC5AEB.md)
- 2016-04-30 to 2016-07-31 | quarterly_net_income | 320,000,000 United States dollar | superseded | [clm_0CC40575FF89](/claim/clm_0CC40575FF89.md)
- 2016-04-30 to 2016-07-31 | total_assets | 78,064,000,000 United States dollar | superseded | [clm_39740ADCDEBF](/claim/clm_39740ADCDEBF.md)
- 2016-04-30 to 2016-07-31 | quarterly_revenue | 12,711,000,000 United States dollar | superseded | [clm_76A8DC601BDC](/claim/clm_76A8DC601BDC.md)
- 2016-04-30 to 2016-07-31 | quarterly_operating_income | 492,000,000 United States dollar | superseded | [clm_8DD770489771](/claim/clm_8DD770489771.md)
- 2016-04-30 to 2016-07-31 | cash_and_equivalents | 9,010,000,000 United States dollar | superseded | [clm_9843B7DBB60B](/claim/clm_9843B7DBB60B.md)
- 2016-04-30 to 2016-07-31 | total_equity | 31,634,000,000 United States dollar | superseded | [clm_9B18596BACFE](/claim/clm_9B18596BACFE.md)
- 2016-04-30 to 2016-07-31 | quarterly_research_and_development | 624,000,000 United States dollar | superseded | [clm_CB944972DB67](/claim/clm_CB944972DB67.md)
- 2016-05-31 to 2016-08-31 | shares_outstanding | 1,661,714,690 shares | superseded | [clm_4A25DA3CA0EC](/claim/clm_4A25DA3CA0EC.md)
- 2016-07-31 to 2016-10-31 | total_equity | 32,426,000,000 United States dollar | superseded | [clm_3EDB207CA2CF](/claim/clm_3EDB207CA2CF.md)
- 2016-07-31 to 2016-10-31 | total_assets | 78,821,000,000 United States dollar | superseded | [clm_9C0DE1FF249B](/claim/clm_9C0DE1FF249B.md)
- 2016-07-31 to 2017-01-31 | quarterly_research_and_development | 555,000,000 United States dollar | superseded | [clm_A0ABEAF2C42A](/claim/clm_A0ABEAF2C42A.md)
- 2016-07-31 to 2017-01-31 | quarterly_revenue | 12,210,000,000 United States dollar | superseded | [clm_B08C0A5CAE0C](/claim/clm_B08C0A5CAE0C.md)
- 2016-07-31 to 2016-10-31 | cash_and_equivalents | 10,743,000,000 United States dollar | superseded | [clm_CBB0E53B4510](/claim/clm_CBB0E53B4510.md)
- 2016-07-31 to 2017-01-31 | quarterly_net_income | 2,272,000,000 United States dollar | superseded | [clm_D8AD1FD8CCA2](/claim/clm_D8AD1FD8CCA2.md)
- 2016-07-31 to 2017-01-31 | quarterly_operating_income | 2,497,000,000 United States dollar | superseded | [clm_E156BE2A3B54](/claim/clm_E156BE2A3B54.md)
- 2016-08-31 to 2016-11-30 | shares_outstanding | 1,665,537,308 shares | superseded | [clm_BF3C28D017E0](/claim/clm_BF3C28D017E0.md)
- 2016-10-31 to 2017-10-31 | revenue | 50,123,000,000 United States dollar | superseded | [clm_03B63FF468D2](/claim/clm_03B63FF468D2.md)
- 2016-10-31 to 2016-11-01 | operating_income | 4,150,000,000 United States dollar | superseded | [clm_09430A31E9A9](/claim/clm_09430A31E9A9.md)
- 2016-10-31 to 2017-01-31 | total_assets | 79,679,000,000 United States dollar | superseded | [clm_4A7D9118A26B](/claim/clm_4A7D9118A26B.md)
- 2016-10-31 to 2017-01-31 | cash_and_equivalents | 12,987,000,000 United States dollar | superseded | [clm_7085F8861D40](/claim/clm_7085F8861D40.md)
- 2016-10-31 to 2016-11-01 | net_income | 3,161,000,000 United States dollar | superseded | [clm_BE10F35A2CAB](/claim/clm_BE10F35A2CAB.md)
- 2016-10-31 to 2017-01-31 | total_equity | 31,448,000,000 United States dollar | superseded | [clm_BEAA52F52121](/claim/clm_BEAA52F52121.md)
- 2016-10-31 to 2017-10-31 | research_and_development | 2,298,000,000 United States dollar | superseded | [clm_DD2D67B32166](/claim/clm_DD2D67B32166.md)
- 2016-11-01 to 2017-10-31 | operating_income | 625,000,000 United States dollar | superseded | [clm_2FE9A7CAC997](/claim/clm_2FE9A7CAC997.md)
- 2016-11-01 to 2017-10-31 | net_income | 344,000,000 United States dollar | superseded | [clm_82C7329448F0](/claim/clm_82C7329448F0.md)
- 2016-11-30 to 2017-02-28 | shares_outstanding | 1,664,817,197 shares | superseded | [clm_276D4C4CE44E](/claim/clm_276D4C4CE44E.md)
- 2016-12-31 to 2018-10-31 | employees | 195,000 | superseded | [clm_4020F07D3CDC](/claim/clm_4020F07D3CDC.md)
- 2016-12-31 to 2017-01-31 | total_assets | 79,679,000,000 United States dollar | superseded | [clm_CEEB4C8480B1](/claim/clm_CEEB4C8480B1.md)
- 2016-12-31 to 2017-10-31 | revenue | 50,123,000,000 United States dollar | superseded | [clm_E4CC647F7E23](/claim/clm_E4CC647F7E23.md)

## 2017

- 2017-01-31 to 2017-04-30 | total_equity | 31,501,000,000 United States dollar | superseded | [clm_8B5AE1E3A555](/claim/clm_8B5AE1E3A555.md)
- 2017-01-31 to 2017-04-30 | quarterly_revenue | 11,407,000,000 United States dollar | superseded | [clm_8CB785900712](/claim/clm_8CB785900712.md)
- 2017-01-31 to 2017-04-30 | quarterly_research_and_development | 485,000,000 United States dollar | superseded | [clm_9944A7732D54](/claim/clm_9944A7732D54.md)
- 2017-01-31 to 2017-04-30 | cash_and_equivalents | 9,858,000,000 United States dollar | superseded | [clm_A155AE945582](/claim/clm_A155AE945582.md)
- 2017-01-31 to 2017-04-30 | total_assets | 76,662,000,000 United States dollar | superseded | [clm_EC95F901397F](/claim/clm_EC95F901397F.md)
- 2017-01-31 to 2017-04-30 | quarterly_operating_income | 463,000,000 United States dollar | superseded | [clm_FF2BD872CCE2](/claim/clm_FF2BD872CCE2.md)
- 2017-02-28 to 2017-05-31 | shares_outstanding | 1,657,704,510 shares | superseded | [clm_3BE71F0B99D9](/claim/clm_3BE71F0B99D9.md)
- 2017-04-30 to 2017-07-31 | cash_and_equivalents | 8,101,000,000 United States dollar | superseded | [clm_16322A5F7E79](/claim/clm_16322A5F7E79.md)
- 2017-04-30 to 2017-07-31 | total_equity | 29,011,000,000 United States dollar | superseded | [clm_257820A1DBF2](/claim/clm_257820A1DBF2.md)
- 2017-04-30 to 2017-07-31 | quarterly_revenue | 7,445,000,000 United States dollar | superseded | [clm_676DC40AE89E](/claim/clm_676DC40AE89E.md)
- 2017-04-30 to 2017-07-31 | quarterly_net_income | -612,000,000 United States dollar | superseded | [clm_93CDC52FFE61](/claim/clm_93CDC52FFE61.md)
- 2017-04-30 to 2017-07-31 | quarterly_operating_income | 182,000,000 United States dollar | superseded | [clm_9844D9B8041D](/claim/clm_9844D9B8041D.md)
- 2017-04-30 to 2017-07-31 | total_assets | 67,470,000,000 United States dollar | superseded | [clm_B7A4B4465F33](/claim/clm_B7A4B4465F33.md)
- 2017-04-30 to 2017-07-31 | quarterly_research_and_development | 486,000,000 United States dollar | superseded | [clm_D8050C32633F](/claim/clm_D8050C32633F.md)
- 2017-05-31 to 2017-08-31 | shares_outstanding | 1,642,630,237 shares | superseded | [clm_B4740D28CF75](/claim/clm_B4740D28CF75.md)
- 2017-07-14 to 2026-10-28 | market_cap | 27,800,000,000 United States dollar | superseded | [clm_C2DE957C717C](/claim/clm_C2DE957C717C.md)
- 2017-07-31 to 2018-01-31 | quarterly_operating_income | 147,000,000 United States dollar | superseded | [clm_081700A2219C](/claim/clm_081700A2219C.md)
- 2017-07-31 to 2018-01-31 | quarterly_revenue | 8,209,000,000 United States dollar | superseded | [clm_382438045510](/claim/clm_382438045510.md)
- 2017-07-31 to 2017-10-31 | cash_and_equivalents | 7,757,000,000 United States dollar | superseded | [clm_4C2667DFD064](/claim/clm_4C2667DFD064.md)
- 2017-07-31 to 2018-01-31 | quarterly_net_income | 165,000,000 United States dollar | superseded | [clm_5F68A571E09F](/claim/clm_5F68A571E09F.md)
- 2017-07-31 to 2017-10-31 | total_assets | 70,931,000,000 United States dollar | superseded | [clm_6A96B37D9D52](/claim/clm_6A96B37D9D52.md)
- 2017-07-31 to 2017-10-31 | total_equity | 29,012,000,000 United States dollar | superseded | [clm_B6D7986047BE](/claim/clm_B6D7986047BE.md)
- 2017-07-31 to 2018-01-31 | quarterly_research_and_development | 508,000,000 United States dollar | superseded | [clm_E9631503AE4C](/claim/clm_E9631503AE4C.md)
- 2017-08-31 to 2017-11-30 | shares_outstanding | 1,619,464,166 shares | superseded | [clm_4C357EAFFE07](/claim/clm_4C357EAFFE07.md)
- 2017-10-31 to 2018-01-31 | cash_and_equivalents | 9,579,000,000 United States dollar | superseded | [clm_307D68B54256](/claim/clm_307D68B54256.md)
- 2017-10-31 to 2018-10-31 | research_and_development | 1,486,000,000 United States dollar | superseded | [clm_3D47B709E239](/claim/clm_3D47B709E239.md)
- 2017-10-31 to 2018-10-31 | revenue | 28,871,000,000 United States dollar | superseded | [clm_7C418203C671](/claim/clm_7C418203C671.md)
- 2017-10-31 to 2017-11-01 | operating_income | 625,000,000 United States dollar | superseded | [clm_931AEBBF3307](/claim/clm_931AEBBF3307.md)
- 2017-10-31 to 2018-01-31 | total_assets | 61,406,000,000 United States dollar | superseded | [clm_96158A82D483](/claim/clm_96158A82D483.md)
- 2017-10-31 to 2018-01-31 | total_equity | 23,466,000,000 United States dollar | superseded | [clm_B8672D977565](/claim/clm_B8672D977565.md)
- 2017-10-31 to 2017-11-01 | net_income | 344,000,000 United States dollar | superseded | [clm_FF4C6F426513](/claim/clm_FF4C6F426513.md)
- 2017-11-01 to 2018-10-31 | net_income | 1,908,000,000 United States dollar | superseded | [clm_4229366AF6BD](/claim/clm_4229366AF6BD.md)
- 2017-11-01 to 2018-10-31 | operating_income | 1,858,000,000 United States dollar | superseded | [clm_4256491BC53D](/claim/clm_4256491BC53D.md)
- 2017-11-30 to 2018-02-28 | shares_outstanding | 1,593,885,581 shares | superseded | [clm_B38261BCCDFF](/claim/clm_B38261BCCDFF.md)
- 2017-12-31 to 2018-10-31 | revenue | 28,871,000,000 United States dollar | superseded | [clm_C990CF94C621](/claim/clm_C990CF94C621.md)

## 2018

- 2018-01-01 | board_member | Antonio Neri | unverified | [clm_5F1DECADA997](/claim/clm_5F1DECADA997.md)
- 2018-01-31 to 2018-04-30 | cash_and_equivalents | 7,673,000,000 United States dollar | superseded | [clm_096A458CDFD1](/claim/clm_096A458CDFD1.md)
- 2018-01-31 to 2018-04-30 | quarterly_revenue | 7,674,000,000 United States dollar | superseded | [clm_5BDEFC54B194](/claim/clm_5BDEFC54B194.md)
- 2018-01-31 to 2018-04-30 | quarterly_research_and_development | 388,000,000 United States dollar | superseded | [clm_5E7BD993A857](/claim/clm_5E7BD993A857.md)
- 2018-01-31 to 2018-04-30 | quarterly_operating_income | 261,000,000 United States dollar | superseded | [clm_7F5962FEB9C7](/claim/clm_7F5962FEB9C7.md)
- 2018-01-31 to 2018-04-30 | quarterly_net_income | 1,436,000,000 United States dollar | superseded | [clm_A6C8B5F4669D](/claim/clm_A6C8B5F4669D.md)
- 2018-01-31 to 2018-04-30 | total_assets | 61,619,000,000 United States dollar | superseded | [clm_E57C8D22CC33](/claim/clm_E57C8D22CC33.md)
- 2018-01-31 to 2018-04-30 | total_equity | 23,951,000,000 United States dollar | superseded | [clm_FEAEB88108F4](/claim/clm_FEAEB88108F4.md)
- 2018-02-01 | ceo | Antonio Neri | unverified | [clm_79F03F1E8610](/claim/clm_79F03F1E8610.md)
- 2018-02-28 to 2018-05-31 | shares_outstanding | 1,553,204,723 shares | superseded | [clm_D1E495C57A89](/claim/clm_D1E495C57A89.md)
- 2018-04-30 to 2018-07-31 | total_equity | 23,932,000,000 United States dollar | superseded | [clm_10DDE02140D4](/claim/clm_10DDE02140D4.md)
- 2018-04-30 to 2018-07-31 | quarterly_operating_income | 397,000,000 United States dollar | superseded | [clm_63893A753B87](/claim/clm_63893A753B87.md)
- 2018-04-30 to 2018-07-31 | quarterly_research_and_development | 402,000,000 United States dollar | superseded | [clm_7B1FBA293A22](/claim/clm_7B1FBA293A22.md)
- 2018-04-30 to 2018-07-31 | cash_and_equivalents | 6,986,000,000 United States dollar | superseded | [clm_C29428BCC912](/claim/clm_C29428BCC912.md)
- 2018-04-30 to 2018-07-31 | quarterly_net_income | 778,000,000 United States dollar | superseded | [clm_D589D74EADDD](/claim/clm_D589D74EADDD.md)
- 2018-04-30 to 2018-07-31 | total_assets | 59,876,000,000 United States dollar | superseded | [clm_E143FBB0949D](/claim/clm_E143FBB0949D.md)
- 2018-04-30 to 2018-07-31 | quarterly_revenue | 7,468,000,000 United States dollar | superseded | [clm_F16E83783F76](/claim/clm_F16E83783F76.md)
- 2018-05-31 to 2018-08-20 | shares_outstanding | 1,513,961,241 shares | superseded | [clm_11E25803BCB0](/claim/clm_11E25803BCB0.md)
- 2018-07-31 to 2018-10-31 | total_assets | 57,513,000,000 United States dollar | superseded | [clm_261983E0EDBC](/claim/clm_261983E0EDBC.md)
- 2018-07-31 to 2018-10-31 | cash_and_equivalents | 5,193,000,000 United States dollar | superseded | [clm_3F361EBFE637](/claim/clm_3F361EBFE637.md)
- 2018-07-31 to 2019-01-31 | quarterly_operating_income | 516,000,000 United States dollar | superseded | [clm_7A0EB9F81589](/claim/clm_7A0EB9F81589.md)
- 2018-07-31 to 2018-10-31 | total_equity | 23,426,000,000 United States dollar | superseded | [clm_869925D25271](/claim/clm_869925D25271.md)
- 2018-07-31 to 2019-01-31 | quarterly_revenue | 7,764,000,000 United States dollar | superseded | [clm_AC3D93F72671](/claim/clm_AC3D93F72671.md)
- 2018-07-31 to 2019-01-31 | quarterly_research_and_development | 434,000,000 United States dollar | superseded | [clm_BB9FA6BCB61C](/claim/clm_BB9FA6BCB61C.md)
- 2018-07-31 to 2019-01-31 | quarterly_net_income | 451,000,000 United States dollar | superseded | [clm_D29136694006](/claim/clm_D29136694006.md)
- 2018-08-20 to 2018-11-30 | shares_outstanding | 1,471,648,283 shares | superseded | [clm_60557BD3DF3C](/claim/clm_60557BD3DF3C.md)
- 2018-10-31 to 2018-11-01 | operating_income | 1,858,000,000 United States dollar | superseded | [clm_47BFEC9BE0DF](/claim/clm_47BFEC9BE0DF.md)
- 2018-10-31 to 2018-11-01 | revenue | 30,852,000,000 United States dollar | superseded | [clm_499F6337216C](/claim/clm_499F6337216C.md)
- 2018-10-31 to 2018-11-01 | total_equity | 21,239,000,000 United States dollar | superseded | [clm_5ED5DD890A5B](/claim/clm_5ED5DD890A5B.md)
- 2018-10-31 to 2025-10-31 | employees | 60,000 | superseded | [clm_8E3B32628AF0](/claim/clm_8E3B32628AF0.md)
- 2018-10-31 to 2018-11-01 | net_income | 1,908,000,000 United States dollar | superseded | [clm_A0E2CD80E85C](/claim/clm_A0E2CD80E85C.md)
- 2018-10-31 to 2019-10-31 | research_and_development | 1,663,000,000 United States dollar | superseded | [clm_A90D5CCC3109](/claim/clm_A90D5CCC3109.md)
- 2018-10-31 to 2019-01-31 | cash_and_equivalents | 4,880,000,000 United States dollar | superseded | [clm_BE3C0DDD14D7](/claim/clm_BE3C0DDD14D7.md)
- 2018-10-31 to 2018-11-01 | total_assets | 55,493,000,000 United States dollar | superseded | [clm_EFB8EB74DA62](/claim/clm_EFB8EB74DA62.md)
- 2018-11-01 to 2018-12-31 | revenue | 29,135,000,000 United States dollar | superseded | [clm_195A453E5322](/claim/clm_195A453E5322.md)
- 2018-11-01 to 2019-01-31 | total_equity | -5,775,000,000 United States dollar | superseded | [clm_6336EEDBB4FD](/claim/clm_6336EEDBB4FD.md)
- 2018-11-01 to 2019-01-31 | total_assets | 20,469,000,000 United States dollar | superseded | [clm_7365F60CD6B1](/claim/clm_7365F60CD6B1.md)
- 2018-11-01 to 2019-10-31 | net_income | 1,049,000,000 United States dollar | superseded | [clm_74ECD8B75A41](/claim/clm_74ECD8B75A41.md)
- 2018-11-01 to 2019-10-31 | operating_income | 1,274,000,000 United States dollar | superseded | [clm_8B54D8141439](/claim/clm_8B54D8141439.md)
- 2018-11-30 to 2019-02-25 | shares_outstanding | 1,398,678,425 shares | superseded | [clm_372DE6ADB711](/claim/clm_372DE6ADB711.md)
- 2018-12-31 to 2019-10-31 | revenue | 30,852,000,000 United States dollar | superseded | [clm_FF1FE69C5C78](/claim/clm_FF1FE69C5C78.md)

## 2019

- 2019-01-31 to 2019-04-30 | quarterly_research_and_development | 466,000,000 United States dollar | superseded | [clm_2779F6F88B5E](/claim/clm_2779F6F88B5E.md)
- 2019-01-31 to 2019-04-30 | quarterly_revenue | 7,553,000,000 United States dollar | superseded | [clm_29962B50C464](/claim/clm_29962B50C464.md)
- 2019-01-31 to 2019-04-30 | quarterly_net_income | 177,000,000 United States dollar | superseded | [clm_43C650F66FCC](/claim/clm_43C650F66FCC.md)
- 2019-01-31 to 2019-04-30 | total_equity | 18,293,000,000 United States dollar | superseded | [clm_BBF11395657A](/claim/clm_BBF11395657A.md)
- 2019-01-31 to 2019-04-30 | total_assets | 51,758,000,000 United States dollar | superseded | [clm_C6562CB3AA0F](/claim/clm_C6562CB3AA0F.md)
- 2019-01-31 to 2019-04-30 | cash_and_equivalents | 3,781,000,000 United States dollar | superseded | [clm_CD7B95C914DF](/claim/clm_CD7B95C914DF.md)
- 2019-01-31 to 2019-04-30 | quarterly_operating_income | 456,000,000 United States dollar | superseded | [clm_FFDAFD56AC99](/claim/clm_FFDAFD56AC99.md)
- 2019-02-25 to 2019-05-20 | shares_outstanding | 1,370,378,287 shares | superseded | [clm_5C43D344F07A](/claim/clm_5C43D344F07A.md)
- 2019-04-30 to 2019-07-31 | total_assets | 51,140,000,000 United States dollar | superseded | [clm_06FE54C79872](/claim/clm_06FE54C79872.md)
- 2019-04-30 to 2019-07-31 | cash_and_equivalents | 3,585,000,000 United States dollar | superseded | [clm_5704EF43D882](/claim/clm_5704EF43D882.md)
- 2019-04-30 to 2019-07-31 | quarterly_operating_income | 434,000,000 United States dollar | superseded | [clm_767CECF5F9E7](/claim/clm_767CECF5F9E7.md)
- 2019-04-30 to 2019-07-31 | total_equity | 18,198,000,000 United States dollar | superseded | [clm_7F883B8A59E6](/claim/clm_7F883B8A59E6.md)
- 2019-04-30 to 2019-07-31 | quarterly_research_and_development | 457,000,000 United States dollar | superseded | [clm_AB13E9F36EBA](/claim/clm_AB13E9F36EBA.md)
- 2019-04-30 to 2019-07-31 | quarterly_net_income | 419,000,000 United States dollar | superseded | [clm_B7C9A1E776E0](/claim/clm_B7C9A1E776E0.md)
- 2019-04-30 to 2019-07-31 | quarterly_revenue | 7,150,000,000 United States dollar | superseded | [clm_C03088411B5E](/claim/clm_C03088411B5E.md)
- 2019-05-20 to 2019-08-20 | shares_outstanding | 1,339,148,624 shares | superseded | [clm_F42D0F8F5E9E](/claim/clm_F42D0F8F5E9E.md)
- 2019-07-31 to 2020-01-31 | quarterly_net_income | -27,000,000 United States dollar | superseded | [clm_05CD93C35C28](/claim/clm_05CD93C35C28.md)
- 2019-07-31 to 2019-10-31 | cash_and_equivalents | 3,693,000,000 United States dollar | superseded | [clm_25375E5FC3C9](/claim/clm_25375E5FC3C9.md)
- 2019-07-31 to 2019-10-31 | total_assets | 50,760,000,000 United States dollar | superseded | [clm_B03519505904](/claim/clm_B03519505904.md)
- 2019-07-31 to 2019-10-31 | total_equity | 17,533,000,000 United States dollar | superseded | [clm_BE55C96AFFE2](/claim/clm_BE55C96AFFE2.md)
- 2019-07-31 to 2020-01-31 | quarterly_operating_income | -76,000,000 United States dollar | superseded | [clm_C8C7ACF41851](/claim/clm_C8C7ACF41851.md)
- 2019-07-31 to 2020-01-31 | quarterly_research_and_development | 481,000,000 United States dollar | superseded | [clm_CA3CFF27969A](/claim/clm_CA3CFF27969A.md)
- 2019-07-31 to 2020-01-31 | quarterly_revenue | 7,217,000,000 United States dollar | superseded | [clm_DEC39F785B8F](/claim/clm_DEC39F785B8F.md)
- 2019-08-20 to 2019-11-30 | shares_outstanding | 1,305,601,258 shares | superseded | [clm_089419D995A0](/claim/clm_089419D995A0.md)
- 2019-10-31 to 2020-10-31 | research_and_development | 1,842,000,000 United States dollar | superseded | [clm_2427EE0BB659](/claim/clm_2427EE0BB659.md)
- 2019-10-31 to 2019-11-01 | operating_income | 1,274,000,000 United States dollar | superseded | [clm_35FF2E1012AF](/claim/clm_35FF2E1012AF.md)
- 2019-10-31 to 2020-01-31 | cash_and_equivalents | 3,753,000,000 United States dollar | superseded | [clm_3FD8848A0104](/claim/clm_3FD8848A0104.md)
- 2019-10-31 to 2020-01-31 | total_assets | 51,803,000,000 United States dollar | superseded | [clm_5CE7107A3AA3](/claim/clm_5CE7107A3AA3.md)
- 2019-10-31 to 2020-01-31 | total_equity | 17,098,000,000 United States dollar | superseded | [clm_81B14E6F9A64](/claim/clm_81B14E6F9A64.md)
- 2019-10-31 to 2019-11-01 | revenue | 29,135,000,000 United States dollar | superseded | [clm_8F8C2405076A](/claim/clm_8F8C2405076A.md)
- 2019-10-31 to 2019-11-01 | net_income | 1,049,000,000 United States dollar | superseded | [clm_C42E8372706B](/claim/clm_C42E8372706B.md)
- 2019-11-01 to 2020-10-31 | net_income | -322,000,000 United States dollar | superseded | [clm_AB1E11F3F387](/claim/clm_AB1E11F3F387.md)
- 2019-11-01 to 2020-10-31 | operating_income | -329,000,000 United States dollar | superseded | [clm_E1589532CF1B](/claim/clm_E1589532CF1B.md)
- 2019-11-01 to 2020-10-31 | revenue | 26,982,000,000 United States dollar | superseded | [clm_F37E03D0844B](/claim/clm_F37E03D0844B.md)
- 2019-11-30 to 2020-02-28 | shares_outstanding | 1,292,925,893 shares | superseded | [clm_D0E96A2A23A8](/claim/clm_D0E96A2A23A8.md)

## 2020

- 2020-01-31 to 2020-04-30 | quarterly_operating_income | 348,000,000 United States dollar | superseded | [clm_2B4283004B86](/claim/clm_2B4283004B86.md)
- 2020-01-31 to 2020-04-30 | quarterly_net_income | 333,000,000 United States dollar | superseded | [clm_2CC2C2A48D8D](/claim/clm_2CC2C2A48D8D.md)
- 2020-01-31 to 2020-04-30 | cash_and_equivalents | 3,171,000,000 United States dollar | superseded | [clm_4EE6D2ECF0D2](/claim/clm_4EE6D2ECF0D2.md)
- 2020-01-31 to 2020-04-30 | quarterly_revenue | 6,949,000,000 United States dollar | superseded | [clm_5114B9AB27C6](/claim/clm_5114B9AB27C6.md)
- 2020-01-31 to 2020-04-30 | total_assets | 52,244,000,000 United States dollar | superseded | [clm_57C3E338F284](/claim/clm_57C3E338F284.md)
- 2020-01-31 to 2020-04-30 | total_equity | 17,189,000,000 United States dollar | superseded | [clm_B0067AB81297](/claim/clm_B0067AB81297.md)
- 2020-02-28 to 2020-05-28 | shares_outstanding | 1,288,341,672 shares | superseded | [clm_BDC26208F24D](/claim/clm_BDC26208F24D.md)
- 2020-04-30 to 2020-07-31 | quarterly_revenue | 6,009,000,000 United States dollar | superseded | [clm_036AC139F25D](/claim/clm_036AC139F25D.md)
- 2020-04-30 to 2020-07-31 | quarterly_net_income | -821,000,000 United States dollar | superseded | [clm_03C541ECA1D6](/claim/clm_03C541ECA1D6.md)
- 2020-04-30 to 2020-07-31 | cash_and_equivalents | 5,131,000,000 United States dollar | superseded | [clm_1C019AA1F45D](/claim/clm_1C019AA1F45D.md)
- 2020-04-30 to 2020-07-31 | quarterly_research_and_development | 450,000,000 United States dollar | superseded | [clm_643F520F1892](/claim/clm_643F520F1892.md)
- 2020-04-30 to 2020-07-31 | total_assets | 54,515,000,000 United States dollar | superseded | [clm_9A31EE8A4507](/claim/clm_9A31EE8A4507.md)
- 2020-04-30 to 2020-07-31 | quarterly_operating_income | -834,000,000 United States dollar | superseded | [clm_E659841F1647](/claim/clm_E659841F1647.md)
- 2020-04-30 to 2020-07-31 | total_equity | 16,210,000,000 United States dollar | superseded | [clm_EFD91D267F25](/claim/clm_EFD91D267F25.md)
- 2020-05-28 to 2020-08-31 | shares_outstanding | 1,284,757,155 shares | superseded | [clm_D3F3DB96EFC5](/claim/clm_D3F3DB96EFC5.md)
- 2020-07-31 to 2021-01-31 | quarterly_net_income | 9,000,000 United States dollar | superseded | [clm_15BC9B230A54](/claim/clm_15BC9B230A54.md)
- 2020-07-31 to 2021-01-31 | quarterly_revenue | 6,816,000,000 United States dollar | superseded | [clm_1883A9922F42](/claim/clm_1883A9922F42.md)
- 2020-07-31 to 2021-01-31 | quarterly_operating_income | 12,000,000 United States dollar | superseded | [clm_25911D70BCFA](/claim/clm_25911D70BCFA.md)
- 2020-07-31 to 2020-10-31 | total_assets | 58,239,000,000 United States dollar | superseded | [clm_3BC9911EC2F1](/claim/clm_3BC9911EC2F1.md)
- 2020-07-31 to 2020-10-31 | total_equity | 16,155,000,000 United States dollar | superseded | [clm_83EECA6B2F07](/claim/clm_83EECA6B2F07.md)
- 2020-07-31 to 2021-01-31 | quarterly_research_and_development | 455,000,000 United States dollar | superseded | [clm_8675ACBCFE36](/claim/clm_8675ACBCFE36.md)
- 2020-07-31 to 2020-10-31 | cash_and_equivalents | 8,465,000,000 United States dollar | superseded | [clm_8E1A4219B42C](/claim/clm_8E1A4219B42C.md)
- 2020-08-31 to 2020-12-07 | shares_outstanding | 1,286,383,563 shares | superseded | [clm_935A916E3ECF](/claim/clm_935A916E3ECF.md)
- 2020-10-31 to 2021-01-31 | total_equity | 16,049,000,000 United States dollar | superseded | [clm_43CD805BFA24](/claim/clm_43CD805BFA24.md)
- 2020-10-31 to 2020-11-01 | revenue | 26,982,000,000 United States dollar | superseded | [clm_7A7B0DC93407](/claim/clm_7A7B0DC93407.md)
- 2020-10-31 to 2020-11-01 | operating_income | -329,000,000 United States dollar | superseded | [clm_8400295D71F9](/claim/clm_8400295D71F9.md)
- 2020-10-31 to 2021-01-31 | cash_and_equivalents | 4,233,000,000 United States dollar | superseded | [clm_8B1D4B9FE4EF](/claim/clm_8B1D4B9FE4EF.md)
- 2020-10-31 to 2021-10-31 | research_and_development | 1,874,000,000 United States dollar | superseded | [clm_CF1D94C76C98](/claim/clm_CF1D94C76C98.md)
- 2020-10-31 to 2021-01-31 | total_assets | 54,015,000,000 United States dollar | superseded | [clm_F357D1B64E34](/claim/clm_F357D1B64E34.md)
- 2020-10-31 to 2020-11-01 | net_income | -322,000,000 United States dollar | superseded | [clm_FD5E8F9B4674](/claim/clm_FD5E8F9B4674.md)
- 2020-11-01 to 2021-10-31 | net_income | 3,427,000,000 United States dollar | superseded | [clm_2116F04E3200](/claim/clm_2116F04E3200.md)
- 2020-11-01 to 2021-10-31 | revenue | 27,784,000,000 United States dollar | superseded | [clm_372DB67DE323](/claim/clm_372DB67DE323.md)
- 2020-11-01 to 2021-10-31 | operating_income | 1,132,000,000 United States dollar | superseded | [clm_D6FBF07FA088](/claim/clm_D6FBF07FA088.md)
- 2020-12-07 to 2021-02-26 | shares_outstanding | 1,293,499,810 shares | superseded | [clm_024C8E1FA0C6](/claim/clm_024C8E1FA0C6.md)

## 2021

- 2021-01-31 to 2021-04-30 | quarterly_net_income | 223,000,000 United States dollar | superseded | [clm_08E7904FF87A](/claim/clm_08E7904FF87A.md)
- 2021-01-31 to 2021-04-30 | cash_and_equivalents | 4,165,000,000 United States dollar | superseded | [clm_3DF062356F6F](/claim/clm_3DF062356F6F.md)
- 2021-01-31 to 2021-04-30 | total_assets | 53,451,000,000 United States dollar | superseded | [clm_7F483C05DE5A](/claim/clm_7F483C05DE5A.md)
- 2021-01-31 to 2021-04-30 | quarterly_operating_income | 222,000,000 United States dollar | superseded | [clm_89C685C7DF9F](/claim/clm_89C685C7DF9F.md)
- 2021-01-31 to 2021-04-30 | quarterly_research_and_development | 468,000,000 United States dollar | superseded | [clm_A86BFF33B110](/claim/clm_A86BFF33B110.md)
- 2021-01-31 to 2021-04-30 | quarterly_revenue | 6,833,000,000 United States dollar | superseded | [clm_C8524033507C](/claim/clm_C8524033507C.md)
- 2021-01-31 to 2021-04-30 | total_equity | 16,212,000,000 United States dollar | superseded | [clm_E31FDBD19ACE](/claim/clm_E31FDBD19ACE.md)
- 2021-02-26 to 2021-05-28 | shares_outstanding | 1,301,145,494 shares | superseded | [clm_320F34DD517E](/claim/clm_320F34DD517E.md)
- 2021-04-30 to 2021-07-31 | total_equity | 16,560,000,000 United States dollar | superseded | [clm_44B050E2CBF5](/claim/clm_44B050E2CBF5.md)
- 2021-04-30 to 2021-07-31 | quarterly_operating_income | 278,000,000 United States dollar | superseded | [clm_770FF4B6105E](/claim/clm_770FF4B6105E.md)
- 2021-04-30 to 2021-07-31 | quarterly_research_and_development | 503,000,000 United States dollar | superseded | [clm_86D9F6EB2C3A](/claim/clm_86D9F6EB2C3A.md)
- 2021-04-30 to 2021-07-31 | cash_and_equivalents | 4,625,000,000 United States dollar | superseded | [clm_BABF9BEC63DB](/claim/clm_BABF9BEC63DB.md)
- 2021-04-30 to 2021-07-31 | quarterly_net_income | 259,000,000 United States dollar | superseded | [clm_C3C5F1770561](/claim/clm_C3C5F1770561.md)
- 2021-04-30 to 2021-07-31 | quarterly_revenue | 6,700,000,000 United States dollar | superseded | [clm_C46BF27C3382](/claim/clm_C46BF27C3382.md)
- 2021-04-30 to 2021-07-31 | total_assets | 54,132,000,000 United States dollar | superseded | [clm_DCBB6BBD7F23](/claim/clm_DCBB6BBD7F23.md)
- 2021-05-28 to 2021-08-30 | shares_outstanding | 1,305,927,541 shares | superseded | [clm_DF5C44993267](/claim/clm_DF5C44993267.md)
- 2021-07-31 to 2021-10-31 | total_equity | 17,020,000,000 United States dollar | superseded | [clm_589578C9853D](/claim/clm_589578C9853D.md)
- 2021-07-31 to 2021-10-31 | total_assets | 56,437,000,000 United States dollar | superseded | [clm_7E67EF2DBB22](/claim/clm_7E67EF2DBB22.md)
- 2021-07-31 to 2022-01-31 | quarterly_revenue | 6,897,000,000 United States dollar | superseded | [clm_906001363C74](/claim/clm_906001363C74.md)
- 2021-07-31 to 2022-01-31 | quarterly_operating_income | 282,000,000 United States dollar | superseded | [clm_B25929A34813](/claim/clm_B25929A34813.md)
- 2021-07-31 to 2021-10-31 | cash_and_equivalents | 5,293,000,000 United States dollar | superseded | [clm_BC714E27EF40](/claim/clm_BC714E27EF40.md)
- 2021-07-31 to 2022-01-31 | quarterly_net_income | 392,000,000 United States dollar | superseded | [clm_C551E7D92507](/claim/clm_C551E7D92507.md)
- 2021-07-31 to 2022-01-31 | quarterly_research_and_development | 506,000,000 United States dollar | superseded | [clm_C6E06842FB53](/claim/clm_C6E06842FB53.md)
- 2021-08-30 to 2021-12-07 | shares_outstanding | 1,308,050,014 shares | superseded | [clm_ACEF0FB6A27E](/claim/clm_ACEF0FB6A27E.md)
- 2021-10-31 to 2021-11-01 | operating_income | 1,132,000,000 United States dollar | superseded | [clm_0E7E40016EB2](/claim/clm_0E7E40016EB2.md)
- 2021-10-31 to 2022-01-31 | cash_and_equivalents | 3,996,000,000 United States dollar | superseded | [clm_46AA27902F93](/claim/clm_46AA27902F93.md)
- 2021-10-31 to 2021-11-01 | net_income | 3,427,000,000 United States dollar | superseded | [clm_712F12133109](/claim/clm_712F12133109.md)
- 2021-10-31 to 2022-10-31 | research_and_development | 1,979,000,000 United States dollar | superseded | [clm_777D8FECC008](/claim/clm_777D8FECC008.md)
- 2021-10-31 to 2022-01-31 | total_assets | 57,699,000,000 United States dollar | superseded | [clm_7EBF9048DD6F](/claim/clm_7EBF9048DD6F.md)
- 2021-10-31 to 2021-11-01 | revenue | 27,784,000,000 United States dollar | superseded | [clm_CA9D857BDCFF](/claim/clm_CA9D857BDCFF.md)
- 2021-10-31 to 2022-01-31 | total_equity | 19,971,000,000 United States dollar | superseded | [clm_FA372E5ADE7D](/claim/clm_FA372E5ADE7D.md)
- 2021-11-01 to 2022-10-31 | operating_income | 782,000,000 United States dollar | superseded | [clm_35763FE92383](/claim/clm_35763FE92383.md)
- 2021-11-01 to 2022-10-31 | net_income | 868,000,000 United States dollar | superseded | [clm_B24A54DE05FD](/claim/clm_B24A54DE05FD.md)
- 2021-11-01 to 2022-10-31 | revenue | 28,496,000,000 United States dollar | superseded | [clm_FE150389C5DA](/claim/clm_FE150389C5DA.md)
- 2021-12-07 to 2022-02-25 | shares_outstanding | 1,293,439,907 shares | superseded | [clm_AC642C6107C0](/claim/clm_AC642C6107C0.md)

## 2022

- 2022-01-31 to 2022-04-30 | quarterly_revenue | 6,961,000,000 United States dollar | superseded | [clm_05B5F972E86E](/claim/clm_05B5F972E86E.md)
- 2022-01-31 to 2022-04-30 | quarterly_net_income | 513,000,000 United States dollar | superseded | [clm_374A0F2C59E4](/claim/clm_374A0F2C59E4.md)
- 2022-01-31 to 2022-04-30 | total_assets | 57,873,000,000 United States dollar | superseded | [clm_562F1A97EB65](/claim/clm_562F1A97EB65.md)
- 2022-01-31 to 2022-04-30 | quarterly_research_and_development | 504,000,000 United States dollar | superseded | [clm_883ABCDC9A97](/claim/clm_883ABCDC9A97.md)
- 2022-01-31 to 2022-04-30 | cash_and_equivalents | 3,861,000,000 United States dollar | superseded | [clm_8A00CDC4ADD1](/claim/clm_8A00CDC4ADD1.md)
- 2022-01-31 to 2022-04-30 | quarterly_operating_income | 448,000,000 United States dollar | superseded | [clm_AC1B93188D48](/claim/clm_AC1B93188D48.md)
- 2022-01-31 to 2022-04-30 | total_equity | 20,318,000,000 United States dollar | superseded | [clm_E0BB7EB38398](/claim/clm_E0BB7EB38398.md)
- 2022-02-25 to 2022-05-30 | shares_outstanding | 1,300,135,740 shares | superseded | [clm_521B5803A66D](/claim/clm_521B5803A66D.md)
- 2022-04-30 to 2022-07-31 | quarterly_research_and_development | 517,000,000 United States dollar | superseded | [clm_084236DC1EB0](/claim/clm_084236DC1EB0.md)
- 2022-04-30 to 2022-07-31 | total_assets | 56,324,000,000 United States dollar | superseded | [clm_0F74840EB3F7](/claim/clm_0F74840EB3F7.md)
- 2022-04-30 to 2022-07-31 | quarterly_net_income | 250,000,000 United States dollar | superseded | [clm_350514D339E9](/claim/clm_350514D339E9.md)
- 2022-04-30 to 2022-07-31 | total_equity | 20,532,000,000 United States dollar | superseded | [clm_5FF5A3C506D3](/claim/clm_5FF5A3C506D3.md)
- 2022-04-30 to 2022-07-31 | quarterly_operating_income | 207,000,000 United States dollar | superseded | [clm_6846F742AAE9](/claim/clm_6846F742AAE9.md)
- 2022-04-30 to 2022-07-31 | cash_and_equivalents | 3,027,000,000 United States dollar | superseded | [clm_80B073D89A8A](/claim/clm_80B073D89A8A.md)
- 2022-04-30 to 2022-07-31 | quarterly_revenue | 6,713,000,000 United States dollar | superseded | [clm_F61E0705F53D](/claim/clm_F61E0705F53D.md)
- 2022-05-30 to 2022-08-26 | shares_outstanding | 1,299,330,455 shares | superseded | [clm_DABF74770C71](/claim/clm_DABF74770C71.md)
- 2022-07-31 to 2023-01-31 | quarterly_operating_income | 466,000,000 United States dollar | superseded | [clm_02AE4632D636](/claim/clm_02AE4632D636.md)
- 2022-07-31 to 2023-01-31 | quarterly_revenue | 6,951,000,000 United States dollar | superseded | [clm_12305573C4E8](/claim/clm_12305573C4E8.md)
- 2022-07-31 to 2022-10-31 | total_assets | 57,675,000,000 United States dollar | superseded | [clm_2329B82C52C6](/claim/clm_2329B82C52C6.md)
- 2022-07-31 to 2023-01-31 | quarterly_research_and_development | 509,000,000 United States dollar | superseded | [clm_2A9280C65CFB](/claim/clm_2A9280C65CFB.md)
- 2022-07-31 to 2022-10-31 | cash_and_equivalents | 3,762,000,000 United States dollar | superseded | [clm_CC5ABFABE93B](/claim/clm_CC5ABFABE93B.md)
- 2022-07-31 to 2023-01-31 | quarterly_net_income | 409,000,000 United States dollar | superseded | [clm_D41D3946EA4F](/claim/clm_D41D3946EA4F.md)
- 2022-07-31 to 2022-10-31 | total_equity | 20,611,000,000 United States dollar | superseded | [clm_F8124633D2B1](/claim/clm_F8124633D2B1.md)
- 2022-08-26 to 2022-12-02 | shares_outstanding | 1,286,700,896 shares | superseded | [clm_E1C5FF771C70](/claim/clm_E1C5FF771C70.md)
- 2022-10-31 to 2023-10-31 | revenue | 28,496,000,000 United States dollar | superseded | [clm_092FB57D5809](/claim/clm_092FB57D5809.md)
- 2022-10-31 to 2023-01-31 | cash_and_equivalents | 4,163,000,000 United States dollar | superseded | [clm_424282EA901D](/claim/clm_424282EA901D.md)
- 2022-10-31 to 2023-10-31 | research_and_development | 2,045,000,000 United States dollar | superseded | [clm_42CC7B758CD9](/claim/clm_42CC7B758CD9.md)
- 2022-10-31 to 2023-01-31 | total_equity | 19,864,000,000 United States dollar | superseded | [clm_5173CA9306CB](/claim/clm_5173CA9306CB.md)
- 2022-10-31 to 2023-10-31 | operating_income | 782,000,000 United States dollar | superseded | [clm_66FA5A1CFCEF](/claim/clm_66FA5A1CFCEF.md)
- 2022-10-31 to 2023-01-31 | total_assets | 57,123,000,000 United States dollar | superseded | [clm_BE835A4033DB](/claim/clm_BE835A4033DB.md)
- 2022-10-31 to 2023-10-31 | net_income | 868,000,000 United States dollar | superseded | [clm_D51BD75C7165](/claim/clm_D51BD75C7165.md)
- 2022-12-02 to 2023-03-02 | shares_outstanding | 1,281,816,851 shares | superseded | [clm_755AB759AC04](/claim/clm_755AB759AC04.md)

## 2023

- 2023-01-10 | board_member | Frank A. D'Amelio | valid | [clm_B4A75C66A9C6](/claim/clm_B4A75C66A9C6.md)
- 2023-01-31 to 2023-04-30 | total_assets | 55,591,000,000 United States dollar | superseded | [clm_099019874F7A](/claim/clm_099019874F7A.md)
- 2023-01-31 to 2023-04-30 | total_equity | 20,011,000,000 United States dollar | superseded | [clm_395E1F3ADD92](/claim/clm_395E1F3ADD92.md)
- 2023-01-31 to 2023-04-30 | quarterly_operating_income | 591,000,000 United States dollar | superseded | [clm_513D66B71FD5](/claim/clm_513D66B71FD5.md)
- 2023-01-31 to 2023-04-30 | quarterly_net_income | 501,000,000 United States dollar | superseded | [clm_87477510F2CE](/claim/clm_87477510F2CE.md)
- 2023-01-31 to 2023-04-30 | quarterly_revenue | 7,809,000,000 United States dollar | superseded | [clm_87ACB647AF69](/claim/clm_87ACB647AF69.md)
- 2023-01-31 to 2023-04-30 | quarterly_research_and_development | 623,000,000 United States dollar | superseded | [clm_B47E2E2E67E4](/claim/clm_B47E2E2E67E4.md)
- 2023-01-31 to 2023-04-30 | cash_and_equivalents | 2,530,000,000 United States dollar | superseded | [clm_E6F53E7FE561](/claim/clm_E6F53E7FE561.md)
- 2023-03-02 to 2023-05-26 | shares_outstanding | 1,295,869,008 shares | superseded | [clm_BFC7F08FB0D6](/claim/clm_BFC7F08FB0D6.md)
- 2023-04-30 to 2023-07-31 | quarterly_research_and_development | 570,000,000 United States dollar | superseded | [clm_1211D0DEB32A](/claim/clm_1211D0DEB32A.md)
- 2023-04-30 to 2023-07-31 | quarterly_operating_income | 520,000,000 United States dollar | superseded | [clm_1271B6052FF6](/claim/clm_1271B6052FF6.md)
- 2023-04-30 to 2023-07-31 | cash_and_equivalents | 2,781,000,000 United States dollar | superseded | [clm_162F215B90F5](/claim/clm_162F215B90F5.md)
- 2023-04-30 to 2023-07-31 | total_equity | 20,366,000,000 United States dollar | superseded | [clm_919C1C834472](/claim/clm_919C1C834472.md)
- 2023-04-30 to 2023-07-31 | quarterly_revenue | 6,973,000,000 United States dollar | superseded | [clm_FA29500043BC](/claim/clm_FA29500043BC.md)
- 2023-04-30 to 2023-07-31 | quarterly_net_income | 418,000,000 United States dollar | superseded | [clm_FAF23D7732D8](/claim/clm_FAF23D7732D8.md)
- 2023-04-30 to 2023-07-31 | total_assets | 55,549,000,000 United States dollar | superseded | [clm_FB6BF1563F14](/claim/clm_FB6BF1563F14.md)
- 2023-05-26 to 2023-08-24 | shares_outstanding | 1,291,518,139 shares | superseded | [clm_0792147050E5](/claim/clm_0792147050E5.md)
- 2023-06-14 | board_member | Bethany Mayer | valid | [clm_A6DF000DD858](/claim/clm_A6DF000DD858.md)
- 2023-07-31 to 2024-01-31 | quarterly_net_income | 464,000,000 United States dollar | superseded | [clm_460F85E35623](/claim/clm_460F85E35623.md)
- 2023-07-31 to 2023-10-31 | cash_and_equivalents | 2,919,000,000 United States dollar | superseded | [clm_480141ED30BE](/claim/clm_480141ED30BE.md)
- 2023-07-31 to 2024-01-31 | quarterly_operating_income | 471,000,000 United States dollar | superseded | [clm_823245DC22E4](/claim/clm_823245DC22E4.md)
- 2023-07-31 to 2024-01-31 | quarterly_revenue | 7,002,000,000 United States dollar | superseded | [clm_A8145FB7B40D](/claim/clm_A8145FB7B40D.md)
- 2023-07-31 to 2023-10-31 | total_assets | 56,415,000,000 United States dollar | superseded | [clm_BC3780E68D62](/claim/clm_BC3780E68D62.md)
- 2023-07-31 to 2024-01-31 | quarterly_research_and_development | 578,000,000 United States dollar | superseded | [clm_D35082AB63D5](/claim/clm_D35082AB63D5.md)
- 2023-07-31 to 2023-10-31 | total_equity | 20,622,000,000 United States dollar | superseded | [clm_D8CD05EE847C](/claim/clm_D8CD05EE847C.md)
- 2023-08-24 to 2023-12-11 | shares_outstanding | 1,282,864,719 shares | superseded | [clm_6A6A406796A0](/claim/clm_6A6A406796A0.md)
- 2023-08-25 | cfo | Jeremy K. Cox | valid | [clm_95CB2BDE0BE7](/claim/clm_95CB2BDE0BE7.md)
- 2023-10-31 to 2024-10-31 | net_income | 2,025,000,000 United States dollar | superseded | [clm_19272369B0FF](/claim/clm_19272369B0FF.md)
- 2023-10-31 to 2024-10-31 | operating_income | 2,089,000,000 United States dollar | superseded | [clm_6A286B5626B1](/claim/clm_6A286B5626B1.md)
- 2023-10-31 to 2024-10-31 | revenue | 29,135,000,000 United States dollar | superseded | [clm_71918FA1868F](/claim/clm_71918FA1868F.md)
- 2023-10-31 to 2024-01-31 | cash_and_equivalents | 4,270,000,000 United States dollar | superseded | [clm_770C1418E8B4](/claim/clm_770C1418E8B4.md)
- 2023-10-31 to 2024-10-31 | research_and_development | 2,349,000,000 United States dollar | superseded | [clm_7F2892BF176F](/claim/clm_7F2892BF176F.md)
- 2023-10-31 to 2024-01-31 | total_assets | 57,153,000,000 United States dollar | superseded | [clm_A999477803C1](/claim/clm_A999477803C1.md)
- 2023-10-31 to 2024-01-31 | total_equity | 21,182,000,000 United States dollar | superseded | [clm_B608C6FB1DDD](/claim/clm_B608C6FB1DDD.md)
- 2023-12-11 to 2024-02-27 | shares_outstanding | 1,300,000,000 shares | superseded | [clm_966AE1AE59A4](/claim/clm_966AE1AE59A4.md)

## 2024

- 2024-01-15 | cfo | Marie Myers | valid | [clm_9A3DEFC55BFF](/claim/clm_9A3DEFC55BFF.md)
- 2024-01-31 to 2024-04-30 | total_assets | 58,602,000,000 United States dollar | superseded | [clm_09D1168AF8FA](/claim/clm_09D1168AF8FA.md)
- 2024-01-31 to 2024-04-30 | cash_and_equivalents | 3,758,000,000 United States dollar | superseded | [clm_3A05A1DC4303](/claim/clm_3A05A1DC4303.md)
- 2024-01-31 to 2024-04-30 | quarterly_research_and_development | 582,000,000 United States dollar | superseded | [clm_3DCCC2E9B929](/claim/clm_3DCCC2E9B929.md)
- 2024-01-31 to 2024-04-30 | quarterly_revenue | 6,755,000,000 United States dollar | superseded | [clm_5C730EBC8B7D](/claim/clm_5C730EBC8B7D.md)
- 2024-01-31 to 2024-04-30 | quarterly_operating_income | 525,000,000 United States dollar | superseded | [clm_82C87F8F1759](/claim/clm_82C87F8F1759.md)
- 2024-01-31 to 2024-04-30 | total_equity | 21,416,000,000 United States dollar | superseded | [clm_9F039751ED8F](/claim/clm_9F039751ED8F.md)
- 2024-01-31 to 2024-04-30 | quarterly_net_income | 387,000,000 United States dollar | superseded | [clm_9F4B3347A5B6](/claim/clm_9F4B3347A5B6.md)
- 2024-02-27 to 2024-05-28 | shares_outstanding | 1,300,000,000 shares | superseded | [clm_28219F18323C](/claim/clm_28219F18323C.md)
- 2024-04-30 to 2024-07-31 | quarterly_revenue | 7,204,000,000 United States dollar | superseded | [clm_34D6507AA45E](/claim/clm_34D6507AA45E.md)
- 2024-04-30 to 2024-07-31 | total_equity | 21,680,000,000 United States dollar | superseded | [clm_48E5F8C55FB3](/claim/clm_48E5F8C55FB3.md)
- 2024-04-30 to 2024-07-31 | quarterly_research_and_development | 590,000,000 United States dollar | superseded | [clm_49D5486BFD2A](/claim/clm_49D5486BFD2A.md)
- 2024-04-30 to 2024-07-31 | quarterly_operating_income | 425,000,000 United States dollar | superseded | [clm_63FB0D68DCA9](/claim/clm_63FB0D68DCA9.md)
- 2024-04-30 to 2024-07-31 | total_assets | 59,711,000,000 United States dollar | superseded | [clm_88C99423A435](/claim/clm_88C99423A435.md)
- 2024-04-30 to 2024-07-31 | cash_and_equivalents | 2,676,000,000 United States dollar | superseded | [clm_CA1FA0C13483](/claim/clm_CA1FA0C13483.md)
- 2024-04-30 to 2024-07-31 | quarterly_net_income | 314,000,000 United States dollar | superseded | [clm_EEA33340B8D3](/claim/clm_EEA33340B8D3.md)
- 2024-05-28 to 2024-08-29 | shares_outstanding | 1,299,673,270 shares | superseded | [clm_4A65090F6F53](/claim/clm_4A65090F6F53.md)
- 2024-07-31 to 2024-10-31 | total_equity | 22,077,000,000 United States dollar | superseded | [clm_349FD2976D08](/claim/clm_349FD2976D08.md)
- 2024-07-31 to 2025-01-31 | quarterly_net_income | 512,000,000 United States dollar | superseded | [clm_444F06FDFC9D](/claim/clm_444F06FDFC9D.md)
- 2024-07-31 to 2025-01-31 | quarterly_research_and_development | 547,000,000 United States dollar | superseded | [clm_523AD6DAC5B0](/claim/clm_523AD6DAC5B0.md)
- 2024-07-31 to 2025-01-31 | quarterly_operating_income | 547,000,000 United States dollar | superseded | [clm_703E1C644572](/claim/clm_703E1C644572.md)
- 2024-07-31 to 2024-10-31 | cash_and_equivalents | 3,642,000,000 United States dollar | superseded | [clm_87AFC53ED15D](/claim/clm_87AFC53ED15D.md)
- 2024-07-31 to 2024-10-31 | total_assets | 60,852,000,000 United States dollar | superseded | [clm_9DD506E7EC7E](/claim/clm_9DD506E7EC7E.md)
- 2024-07-31 to 2025-01-31 | quarterly_revenue | 7,710,000,000 United States dollar | superseded | [clm_CA3E55FF3548](/claim/clm_CA3E55FF3548.md)
- 2024-08-29 to 2024-12-09 | shares_outstanding | 1,298,668,639 shares | superseded | [clm_9B18A07A1D1F](/claim/clm_9B18A07A1D1F.md)
- 2024-10-31 to 2025-01-31 | total_assets | 71,262,000,000 United States dollar | superseded | [clm_07106C65D4E3](/claim/clm_07106C65D4E3.md)
- 2024-10-31 to 2025-10-31 | revenue | 30,127,000,000 United States dollar | superseded | [clm_48D94A6F632C](/claim/clm_48D94A6F632C.md)
- 2024-10-31 to 2025-10-31 | research_and_development | 2,246,000,000 United States dollar | superseded | [clm_594230EC08D5](/claim/clm_594230EC08D5.md)
- 2024-10-31 to 2025-01-31 | cash_and_equivalents | 14,846,000,000 United States dollar | superseded | [clm_689EAE477051](/claim/clm_689EAE477051.md)
- 2024-10-31 to 2025-10-31 | net_income | 2,579,000,000 United States dollar | superseded | [clm_8EF24DC2D008](/claim/clm_8EF24DC2D008.md)
- 2024-10-31 to 2025-01-31 | total_equity | 24,816,000,000 United States dollar | superseded | [clm_944BF85CFA7D](/claim/clm_944BF85CFA7D.md)
- 2024-10-31 to 2025-10-31 | operating_income | 2,190,000,000 United States dollar | superseded | [clm_C81EF48D914A](/claim/clm_C81EF48D914A.md)
- 2024-12-09 to 2025-02-28 | shares_outstanding | 1,315,333,942 shares | superseded | [clm_179A2D7C0E3B](/claim/clm_179A2D7C0E3B.md)

## 2025

- 2025-01-31 to 2025-04-30 | total_assets | 70,327,000,000 United States dollar | superseded | [clm_0549A9C7F23E](/claim/clm_0549A9C7F23E.md)
- 2025-01-31 to 2025-04-30 | quarterly_net_income | 627,000,000 United States dollar | superseded | [clm_127A22A4D6E9](/claim/clm_127A22A4D6E9.md)
- 2025-01-31 to 2025-04-30 | quarterly_operating_income | 433,000,000 United States dollar | superseded | [clm_362F9C4C2B02](/claim/clm_362F9C4C2B02.md)
- 2025-01-31 to 2025-04-30 | cash_and_equivalents | 13,431,000,000 United States dollar | superseded | [clm_662A6448F3E0](/claim/clm_662A6448F3E0.md)
- 2025-01-31 to 2025-04-30 | quarterly_research_and_development | 475,000,000 United States dollar | superseded | [clm_D6C88E3226A4](/claim/clm_D6C88E3226A4.md)
- 2025-01-31 to 2025-04-30 | quarterly_revenue | 7,854,000,000 United States dollar | superseded | [clm_DD968117FAA4](/claim/clm_DD968117FAA4.md)
- 2025-01-31 to 2025-04-30 | total_equity | 25,224,000,000 United States dollar | superseded | [clm_E614232E4D08](/claim/clm_E614232E4D08.md)
- 2025-02-28 to 2025-05-28 | shares_outstanding | 1,313,578,244 shares | superseded | [clm_5CFB531A165E](/claim/clm_5CFB531A165E.md)
- 2025-03-06 | restructuring | Cost reduction program cutting workforce to save $350M gross by FY2027 | valid | [clm_318A1F911E98](/claim/clm_318A1F911E98.md)
- 2025-04-30 to 2025-07-31 | quarterly_research_and_development | 540,000,000 United States dollar | superseded | [clm_19D2D7D4B63B](/claim/clm_19D2D7D4B63B.md)
- 2025-04-30 to 2025-07-31 | quarterly_net_income | -1,050,000,000 United States dollar | superseded | [clm_69DAF821C67D](/claim/clm_69DAF821C67D.md)
- 2025-04-30 to 2025-07-31 | quarterly_revenue | 7,627,000,000 United States dollar | superseded | [clm_7814FE4459A2](/claim/clm_7814FE4459A2.md)
- 2025-04-30 to 2025-07-31 | total_assets | 67,854,000,000 United States dollar | superseded | [clm_92081D5BEA91](/claim/clm_92081D5BEA91.md)
- 2025-04-30 to 2025-07-31 | quarterly_operating_income | -1,109,000,000 United States dollar | superseded | [clm_9DBB71405E7B](/claim/clm_9DBB71405E7B.md)
- 2025-04-30 to 2025-07-31 | total_equity | 23,867,000,000 United States dollar | superseded | [clm_E755628873BC](/claim/clm_E755628873BC.md)
- 2025-04-30 to 2025-07-31 | cash_and_equivalents | 11,667,000,000 United States dollar | superseded | [clm_FA3CF09B7314](/claim/clm_FA3CF09B7314.md)
- 2025-05-28 to 2025-08-28 | shares_outstanding | 1,312,215,620 shares | superseded | [clm_08F5397F05A9](/claim/clm_08F5397F05A9.md)
- 2025-07-02 | acquired | Juniper Networks, Inc. | valid | [clm_225469B053C0](/claim/clm_225469B053C0.md)
- 2025-07-16 | board_member | Frank Calderoni | valid | [clm_08383887764B](/claim/clm_08383887764B.md)
- 2025-07-16 | agreement | Elliott Investment Management L.P., Elliott Associates, L.P., and Elliott International, L.P. | valid | [clm_94B564ADB861](/claim/clm_94B564ADB861.md)
- 2025-07-31 to 2025-10-31 | cash_and_equivalents | 4,571,000,000 United States dollar | superseded | [clm_0AF0B73DDDF2](/claim/clm_0AF0B73DDDF2.md)
- 2025-07-31 to 2025-10-31 | total_equity | 24,402,000,000 United States dollar | superseded | [clm_2229692E48D8](/claim/clm_2229692E48D8.md)
- 2025-07-31 to 2026-01-31 | quarterly_revenue | 9,136,000,000 United States dollar | superseded | [clm_6F8C1FE31D96](/claim/clm_6F8C1FE31D96.md)
- 2025-07-31 to 2025-10-31 | total_assets | 77,340,000,000 United States dollar | superseded | [clm_76B921516AAC](/claim/clm_76B921516AAC.md)
- 2025-07-31 to 2026-01-31 | quarterly_research_and_development | 622,000,000 United States dollar | superseded | [clm_95547DB43D6C](/claim/clm_95547DB43D6C.md)
- 2025-07-31 to 2026-01-31 | quarterly_operating_income | 247,000,000 United States dollar | superseded | [clm_98154BD75D6D](/claim/clm_98154BD75D6D.md)
- 2025-08-28 to 2025-12-10 | shares_outstanding | 1,319,450,062 shares | superseded | [clm_B9710DAF7A03](/claim/clm_B9710DAF7A03.md)
- 2025-10-31 | employees | 67,000 | valid | [clm_0CA660555D3F](/claim/clm_0CA660555D3F.md)
- 2025-10-31 | revenue | 34,296,000,000 United States dollar | valid | [clm_2BFA0915E7EC](/claim/clm_2BFA0915E7EC.md)
- 2025-10-31 | net_income | 57,000,000 United States dollar | valid | [clm_32744DB67409](/claim/clm_32744DB67409.md)
- 2025-10-31 to 2026-01-31 | total_assets | 75,906,000,000 United States dollar | superseded | [clm_3B414E39005D](/claim/clm_3B414E39005D.md)
- 2025-10-31 to 2026-01-31 | cash_and_equivalents | 5,773,000,000 United States dollar | superseded | [clm_46B5D86C485A](/claim/clm_46B5D86C485A.md)
- 2025-10-31 | operating_income | -437,000,000 United States dollar | valid | [clm_D651606CA0DD](/claim/clm_D651606CA0DD.md)
- 2025-10-31 | research_and_development | 2,518,000,000 United States dollar | valid | [clm_DFEC40001D7D](/claim/clm_DFEC40001D7D.md)
- 2025-10-31 to 2026-01-31 | total_equity | 24,688,000,000 United States dollar | superseded | [clm_F12DA6700686](/claim/clm_F12DA6700686.md)
- 2025-11-17 | agreement | Unisplendour International Technology Limited | valid | [clm_02A3FA2D5D79](/claim/clm_02A3FA2D5D79.md)
- 2025-12-10 to 2026-03-03 | shares_outstanding | 1,334,533,171 shares | superseded | [clm_FCBAD944F9BC](/claim/clm_FCBAD944F9BC.md)

## 2026

- 2026-01-31 to 2026-04-30 | quarterly_operating_income | 470,000,000 United States dollar | superseded | [clm_1B38D658B98C](/claim/clm_1B38D658B98C.md)
- 2026-01-31 to 2026-04-30 | quarterly_revenue | 9,301,000,000 United States dollar | superseded | [clm_20051372775B](/claim/clm_20051372775B.md)
- 2026-01-31 to 2026-04-30 | quarterly_net_income | 452,000,000 United States dollar | superseded | [clm_28B080B5C090](/claim/clm_28B080B5C090.md)
- 2026-01-31 to 2026-04-30 | total_assets | 75,768,000,000 United States dollar | superseded | [clm_2FB8F8AC18B3](/claim/clm_2FB8F8AC18B3.md)
- 2026-01-31 to 2026-04-30 | quarterly_research_and_development | 744,000,000 United States dollar | superseded | [clm_80AF2CFA64FC](/claim/clm_80AF2CFA64FC.md)
- 2026-01-31 to 2026-04-30 | cash_and_equivalents | 4,841,000,000 United States dollar | superseded | [clm_C183DE485E19](/claim/clm_C183DE485E19.md)
- 2026-01-31 to 2026-04-30 | total_equity | 24,774,000,000 United States dollar | superseded | [clm_FD24809A15EA](/claim/clm_FD24809A15EA.md)
- 2026-03-03 to 2026-05-26 | shares_outstanding | 1,326,854,089 shares | superseded | [clm_F16752C89E47](/claim/clm_F16752C89E47.md)
- 2026-04-30 to 2026-07-31 | quarterly_operating_income | 747,000,000 United States dollar | superseded | [clm_41E5394633C0](/claim/clm_41E5394633C0.md)
- 2026-04-30 to 2026-07-31 | quarterly_revenue | 10,678,000,000 United States dollar | superseded | [clm_5483D2A245EE](/claim/clm_5483D2A245EE.md)
- 2026-04-30 to 2026-07-31 | total_equity | 25,292,000,000 United States dollar | superseded | [clm_5546A49296DC](/claim/clm_5546A49296DC.md)
- 2026-04-30 to 2026-07-31 | cash_and_equivalents | 5,292,000,000 United States dollar | superseded | [clm_64BD6E78DDF1](/claim/clm_64BD6E78DDF1.md)
- 2026-04-30 to 2026-07-31 | quarterly_net_income | 624,000,000 United States dollar | superseded | [clm_BA51AEF2B11D](/claim/clm_BA51AEF2B11D.md)
- 2026-04-30 to 2026-07-31 | quarterly_research_and_development | 922,000,000 United States dollar | superseded | [clm_BDE3965608B1](/claim/clm_BDE3965608B1.md)
- 2026-04-30 to 2026-07-31 | total_assets | 79,512,000,000 United States dollar | superseded | [clm_F4B44CB38490](/claim/clm_F4B44CB38490.md)
- 2026-05-26 to 2026-08-27 | shares_outstanding | 1,324,203,521 shares | superseded | [clm_5FE1C0BCA484](/claim/clm_5FE1C0BCA484.md)
- 2026-06-01 | board_member | Christopher P. Hsu | valid | [clm_D4F616A1B646](/claim/clm_D4F616A1B646.md)
- 2026-07-24 | board_member | David I. Goulden | valid | [clm_CA2583BE8066](/claim/clm_CA2583BE8066.md)
- 2026-07-31 | quarterly_revenue | 12,213,000,000 United States dollar | valid | [clm_15E540B71BB6](/claim/clm_15E540B71BB6.md)
- 2026-07-31 | quarterly_research_and_development | 1,158,000,000 United States dollar | valid | [clm_4B8A3893C08B](/claim/clm_4B8A3893C08B.md)
- 2026-07-31 | total_assets | 83,596,000,000 United States dollar | valid | [clm_6DEFFB125193](/claim/clm_6DEFFB125193.md)
- 2026-07-31 | quarterly_net_income | 1,540,000,000 United States dollar | valid | [clm_B1907A713690](/claim/clm_B1907A713690.md)
- 2026-07-31 | quarterly_operating_income | 1,393,000,000 United States dollar | valid | [clm_C0B58F449BE6](/claim/clm_C0B58F449BE6.md)
- 2026-07-31 | total_equity | 26,514,000,000 United States dollar | valid | [clm_D2577011B6E9](/claim/clm_D2577011B6E9.md)
- 2026-07-31 | cash_and_equivalents | 6,216,000,000 United States dollar | valid | [clm_F13D670C7B81](/claim/clm_F13D670C7B81.md)
- 2026-08-27 | shares_outstanding | 1,327,464,779 shares | valid | [clm_F481BFD94848](/claim/clm_F481BFD94848.md)
- 2026-10-28 | market_cap | 79,250,000,000 United States dollar | unverified | [clm_8AD85CEFD05F](/claim/clm_8AD85CEFD05F.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.